Abstract:Cellular immune responses play a key role in the control of viral infection. The nucleocapsid (N) protein of infectious bronchitis virus (IBV) is a major immunogenic protein that can induce protective immunity. To screen for potential T-cell epitopes on IBV N protein, forty overlapping peptides covering the entirety of the N protein were designed and synthesized. Four T-cell epitope peptides were identified by IFN-γ ELISpot, intracellular cytokine staining, and CFSE lymphocyte proliferation assays; among them, three peptides (N 211–230 , N 271–290 , and N 381–400 ) were CTL epitopes, and one peptide (N 261–280 ) was a dual-specific T-cell epitope, which can be recognized by both CD8 + and CD4 + T cells. Multi-epitope gene transcription cassettes comprising four neutralizing epitope domains and four T-cell epitope peptides were synthesized and inserted into the genome of Newcastle disease virus strain La Sota between the P and M genes. Recombinant IBV multi-epitope vaccine candidate rLa Sota/SBNT was generated via reverse genetics, and its immune protection efficacy was evaluated in specific-pathogen-free chickens. Our results show that rLa Sota/SBNT induced IBV-specific neutralizing antibody and T-cell responses and provided significant protection against homologous and heterologous IBV challenge. Thus, the T-cell epitope peptides identified in this study could be good candidates for IBV vaccine development, and recombinant Newcastle disease virus expressing IBV multi-epitope genes represents a safe and effective vaccine candidate for controlling infectious bronchitis. IMPORTANCE T-cell-mediated immune responses are critical for the elimination of IBV-infected cells. To screen conserved T-cell epitopes in the IBV N protein, forty overlapping peptides covering the entirety of the N protein were designed and synthesized. By combining IFN-γ ELISpot, intracellular cytokine staining, and CFSE lymphocyte proliferation assays, we identified three CTL epitopes and one dual-specific T-cell epitope. The value of T-cell epitope peptides identified in the N protein was further verified by the design of an IBV multi-epitope vaccine. Results show that IBV multi-epitope vaccine candidate rLa Sota/SBNT provided cross protection against challenges with a QX-like or a TW-like IBV strain. So T-cell-mediated immune responses play an important role in the control of viral infection and conserved T-cell epitopes serve as promising candidates for use in multi-epitope vaccine construction. Our results provide a new perspective for the development of a safer and more effective IBV vaccine.

Identification of Novel T-cell Epitopes on Viral Protein VP4 of Infectious Bursal Disease Virus (IBDV) That Play Critical Roles in Eliciting Cellular Immune Response

Plasmid DNA encoding antigens of infectious bursal disease viruses induce protective immune responses in chickens: factors influencing efficacy.

Induction of Protective Immune Response in Chickens Immunized with Plasmid DNA Encoding Antigens of Infectious Bursal Disease Virus

Immunoenhancement on DNA Vaccine of Polyprotein Gene in Infectious Bursal Disease Virus by Co-Delivery with Plasmid Encoding Chicken Interleukin-18.

Identification of neutralizing epitopes on the VP2 protein of infectious bursal disease virus by phage-displayed heptapeptide library screening and synthetic peptide mapping.

Antibody to VP4 protein is an indicator discriminating pathogenic and nonpathogenic IBDV infection.

Identification of chicken CD74 as a novel attachment cellular receptor for infectious bursal disease virus in bursa B lymphocytes.

[Expression of the Infectious Bursal Disease Virus Polyprotein in Vero Cells Using Attenuated Salmonella Typhimurium As Transgenic Carrier].

A Recombinant baculovirus expressing VP2 protein of infectious bursal disease virus (IBDV) and chicken interleukin-18 (ChiL-18) protein protects against very virulent IBDV

Oral DNA vaccination with the polyprotein gene of infectious bursal disease virus (IBDV) delivered by attenuated Salmonella elicits protective immune responses in chickens

Residues 318 and 323 in capsid protein are involved in immune circumvention of the atypical epizootic infection of infectious bursal disease virus

Recombinant Vp2 Protein of Infectious Bursal Disease Virus AH1 Strain Expressed in Insect Cells: a Vaccine Candidate

A recombinant avian antibody against VP2 of infectious bursal disease virus protects chicken from viral infection

Identification of novel T-cell epitopes on infectious bronchitis virus N protein and development of a multi-epitope vaccine

Development and Evaluation of a Recombinant VP2 Neutralizing Epitope Antigen Vaccine Candidate for Infectious Bursal Disease Virus.

Molecular Characterization and Phylogenetic Analysis of Infectious Bursal Disease Viruses Isolated from Chicken in South China in 2011

A Single Amino Acid V4i Substitution in Vp1 Attenuates Virulence of Very Virulent Infectious Bursal Disease Virus (vvibdv) in Spf Chickens and Increases Replication in Cef Cells

Proteome dynamics in primary target organ of infectious bursal disease virus.

Infectious Bursal Disease Virus-Host Interactions: Multifunctional Viral Proteins That Perform Multiple and Differing Jobs

In Vitro Expression and Monoclonal Antibody of Rna-Dependent Rna Polymerase for Infectious Bursal Disease Virus

Antigenic and molecular characterization of infectious bursal disease virus in China from layer chicken flocks